The pharmaceutical industry is continuously evolving, with growing demand for high-quality Active Pharmaceutical Ingredients (APIs). Dulaglutide, a diabetes drug, is a key copyrightple of this trend. To address this demand, US-based manufacturing services are gaining traction. These companies offer a